Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study
- PMID: 33145296
- PMCID: PMC7576005
- DOI: 10.21037/atm-20-4281
Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study
Abstract
Background: On March 11, 2020, the World Health Organization (WHO) officially announced that the coronavirus disease 2019 (COVID-19) had reached global pandemic status. Current studies have found that angiotensin-converting enzyme 2 (ACE2) is a cell surface receptor of the novel coronavirus that plays a vital role in the pathogenesis of COVID-19. It is of immense importance for the prevention of virus transmission and treatment to clarify the distribution and expression of ACE2 in various tissues and organs of the body.
Methods: RNAseq transcriptome data and sex data were obtained from the genotype-tissue expression (GTEx) and the Cancer Genome Atlas (TCGA) databases. We separately analyzed the distribution of ACE2 expression in different tissues in the GTEx and TCGA database, and explored the correlation between sex and ACE2 expression levels. Next, the expression levels of ACE2 in different tissues and organs and its correlation with sex were analyzed once again after combing all samples from the two databases.
Results: ACE2 expression data were collected from the GTEx database for 6738 normal tissues. Six hundred eighteen tumor tissue data were collected from the TCGA database. The results of the analysis are consistent from different databases. The results indicated that the expression of ACE2 was the highest in the small intestines, higher in tissues such as salivary glands in the testicular, kidney, heart, thyroid and adipose tissues, while the expression of ACE2 was lower in tissues such as the spleen, brain, muscle, pituitary, and skin. There were no significant differences in the expression of ACE2 in the different organs when it came to the individual's sex.
Conclusions: Our study deeply explored the distribution and expression of ACE2 in various tissues of the human body. The tissues and organs with high ACE2 expression were consistent with the current clinical and basic research results of the novel coronavirus. Our study is conducive to the discovery of potential target organs for viral infection, to provide a reference for the development of clinical progress of patients with novel coronavirus infection.
Keywords: angiotensin-converting enzyme (ACE); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the Cancer Genome Atlas (TCGA); the genotype-tissue expression (GTEx).
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4281). The authors have no conflicts of interest to declare.
Figures



Similar articles
-
Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.J Med Virol. 2020 Nov;92(11):2556-2566. doi: 10.1002/jmv.26045. Epub 2020 Jun 9. J Med Virol. 2020. PMID: 32441816 Free PMC article.
-
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.Mol Biol Rep. 2020 Jun;47(6):4383-4392. doi: 10.1007/s11033-020-05478-4. Epub 2020 May 14. Mol Biol Rep. 2020. PMID: 32410141 Free PMC article.
-
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.Ann Transl Med. 2020 Apr;8(7):481. doi: 10.21037/atm.2020.03.61. Ann Transl Med. 2020. PMID: 32395525 Free PMC article.
-
Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery.Aging (Albany NY). 2020 Nov 21;13(8):10821-10832. doi: 10.18632/aging.202224. Epub 2020 Nov 21. Aging (Albany NY). 2020. PMID: 33234728 Free PMC article.
-
Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.Pharmaceuticals (Basel). 2021 Aug 17;14(8):805. doi: 10.3390/ph14080805. Pharmaceuticals (Basel). 2021. PMID: 34451902 Free PMC article. Review.
Cited by
-
COVID-19 combined with liver injury: Current challenges and management.World J Clin Cases. 2021 May 26;9(15):3487-3497. doi: 10.12998/wjcc.v9.i15.3487. World J Clin Cases. 2021. PMID: 34046449 Free PMC article. Review.
-
The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review.Adv Respir Med. 2024 Feb 14;92(1):96-109. doi: 10.3390/arm92010013. Adv Respir Med. 2024. PMID: 38392036 Free PMC article. Review.
-
The existence of adrenal insufficiency in patients with COVID-19 pneumonia.Front Endocrinol (Lausanne). 2024 Jul 3;15:1337652. doi: 10.3389/fendo.2024.1337652. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39022343 Free PMC article.
-
COVID-19 infection and thyroid function.Endocr Metab Sci. 2022 Jun 30;7:100122. doi: 10.1016/j.endmts.2022.100122. Epub 2022 Aug 11. Endocr Metab Sci. 2022. PMID: 35971501 Free PMC article.
-
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.Front Endocrinol (Lausanne). 2022 May 4;13:873027. doi: 10.3389/fendo.2022.873027. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35600591 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous